Producing Exosome Therapies Efficiently With A Cell Expansion System
Source: Terumo BCT

Exosome clinical trials are often limited by inefficient manufacturing processes, making clinically relevant doses difficult to obtain. Quantum can efficiently produce large batches of active exosomes from a single donor over a few days. Efficient manufacture in Quantum unlocks the potential of exosome therapies.
Learn about a system researchers are using to expand MSC-derived exosomes and how these exosomes can help treat microvasculature disorders.
access the Datasheet!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Terumo BCT
This website uses cookies to ensure you get the best experience on our website. Learn more